These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 9659085)

  • 1. A prospective 10 year follow up study of patients with neurofibromatosis type 1.
    Cnossen MH; de Goede-Bolder A; van den Broek KM; Waasdorp CM; Oranje AP; Stroink H; Simonsz HJ; van den Ouweland AM; Halley DJ; Niermeijer MF
    Arch Dis Child; 1998 May; 78(5):408-12. PubMed ID: 9659085
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Endocrinologic disorders and optic pathway gliomas in children with neurofibromatosis type 1.
    Cnossen MH; Stam EN; Cooiman LC; Simonsz HJ; Stroink H; Oranje AP; Halley DJ; de Goede-Bolder A; Niermeijer MF; de Muinck Keizer-Schrama SM
    Pediatrics; 1997 Oct; 100(4):667-70. PubMed ID: 9310522
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical features and disease severity in patients with mosaic neurofibromatosis type 1: a single-center study and literature review.
    Ejerskov C; Raundahl M; Gregersen PA; Handrup MM
    Orphanet J Rare Dis; 2021 Apr; 16(1):180. PubMed ID: 33853649
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Is a plexiform neurofibroma pathognomonic of neurofibromatosis type I?
    Lin V; Daniel S; Forte V
    Laryngoscope; 2004 Aug; 114(8):1410-4. PubMed ID: 15280718
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Nevus anemicus in neurofibromatosis type 1: a potential new diagnostic criterion.
    Marque M; Roubertie A; Jaussent A; Carneiro M; Meunier L; Guillot B; Pinson L; Pinson S; Bessis D
    J Am Acad Dermatol; 2013 Nov; 69(5):768-775. PubMed ID: 23972508
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Optic Gliomas in Neurofibromatosis Type 1.
    Parkhurst E; Abboy S
    J Pediatr Ophthalmol Strabismus; 2016 Nov; 53(6):334-338. PubMed ID: 27537249
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Optic pathway gliomas in patients with neurofibromatosis type 1: follow-up of 44 patients.
    Segal L; Darvish-Zargar M; Dilenge ME; Ortenberg J; Polomeno RC
    J AAPOS; 2010 Apr; 14(2):155-8. PubMed ID: 20451859
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Ophthalmological manifestations in segmental neurofibromatosis type 1.
    Ruggieri M; Pavone P; Polizzi A; Di Pietro M; Scuderi A; Gabriele A; Spalice A; Iannetti P
    Br J Ophthalmol; 2004 Nov; 88(11):1429-33. PubMed ID: 15489488
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Minor disease features in neurofibromatosis type 1 (NF1) and their possible value in diagnosis of NF1 in children < or = 6 years and clinically suspected of having NF1. Neurofibromatosis team of Sophia Children's Hospital.
    Cnossen MH; Moons KG; Garssen MP; Pasmans NM; de Goede-Bolder A; Niermeijer MF; Grobbee DE
    J Med Genet; 1998 Aug; 35(8):624-7. PubMed ID: 9719365
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinic-based study of plexiform neurofibromas in neurofibromatosis 1.
    Waggoner DJ; Towbin J; Gottesman G; Gutmann DH
    Am J Med Genet; 2000 May; 92(2):132-5. PubMed ID: 10797438
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Visual outcomes after chemotherapy for optic pathway glioma in children with and without neurofibromatosis type 1: results of the International Society of Paediatric Oncology (SIOP) Low-Grade Glioma 2004 trial UK cohort.
    Falzon K; Drimtzias E; Picton S; Simmons I
    Br J Ophthalmol; 2018 Oct; 102(10):1367-1371. PubMed ID: 29343527
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Neurofibromatosis type 1: a survey of 195 patients].
    Overweg-Plandsoen WC; Weersink RG; Sillevis Smitt JH; Fleury P; van Asperen CJ
    Ned Tijdschr Geneeskd; 1997 Mar; 141(13):624-9. PubMed ID: 9127578
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Neurofibromatosis type 1 complications in the pediatric age: follow-up of a hundred cases].
    Bonnemaison E; Roze-Abert B; Lorette G; Sirinelli D; Boscq M; Mazjoub S; De Courtivron B; Bonnard C; Despert F; Toutain A; Maheut-Lourmière J; Barthez MA; Castelnau P;
    Arch Pediatr; 2006 Jul; 13(7):1009-14. PubMed ID: 16716577
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Children with neurofibroma type 1 treated in the Children's Memorial Health Institute].
    Perek-Polnik M; Filipek I; Dembowska-Bagińska B; Owsik A; Drogosiewicz M; Jurkiewicz E; Perek D
    Med Wieku Rozwoj; 2006; 10(3 Pt 1):699-709. PubMed ID: 17317901
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Optical coherence tomography in the evaluation of neurofibromatosis type-1 subjects with optic pathway gliomas.
    Chang L; El-Dairi MA; Frempong TA; Burner EL; Bhatti MT; Young TL; Leigh F
    J AAPOS; 2010 Dec; 14(6):511-7. PubMed ID: 21168074
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical presentation and prognostic indicators in 100 adults and children with neurofibromatosis 1 associated non-optic pathway brain gliomas.
    Byrne S; Connor S; Lascelles K; Siddiqui A; Hargrave D; Ferner RE
    J Neurooncol; 2017 Jul; 133(3):609-614. PubMed ID: 28593402
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Usefulness of systematic brain magnetic resonance imaging in children with neurofibromatosis type 1].
    Blanchard G; Pinson S; Rousselle C; Lorthois S; Combemale P; Bernard M; Lion Francois L
    Arch Pediatr; 2009 Dec; 16(12):1527-32. PubMed ID: 19864117
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Lymphocyte Subpopulations in Patients With Neurofibromatosis Type 1-associated Optic Pathway Gliomas and Plexiform Neurofibromas.
    Marjanska A; Kubicka M; Kurylo-Rafinska B; Jatczak-Gaca A; Wysocki M; Styczynski J
    Anticancer Res; 2019 Nov; 39(11):6389-6392. PubMed ID: 31704872
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Ophthalmological assessment of children with neurofibromatosis type 1.
    Cassiman C; Legius E; Spileers W; Casteels I
    Eur J Pediatr; 2013 Oct; 172(10):1327-33. PubMed ID: 23708214
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Optic Pathway Glioma and Cerebral Focal Abnormal Signal Intensity in Patients with Neurofibromatosis Type 1: Characteristics, Treatment Choices and Follow-up in 134 Affected Individuals and a Brief Review of the Literature.
    Friedrich RE; Nuding MA
    Anticancer Res; 2016 Aug; 36(8):4095-121. PubMed ID: 27466519
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.